Potential and Challenges of Utilizing Exosomes in Osteoarthritis Therapy (Review)

Overview

Journal Int J Mol Med

Date 2025 Jan 10

PMID 39791222

Authors

Xuesong Chen

Bin Tian

Yiqun Wang

Jiang Zheng

Xin Kang

Affiliations

Soon will be listed here.

Abstract

Exosomes are integral to the pathophysiology of osteoarthritis (OA) due to their roles in mediating intercellular communication and regulating inflammatory processes. Exosomes are integral to the transport of bioactive molecules, such as proteins, lipids and nucleic acids, which can influence chondrocyte behavior and joint homeostasis. Given their properties of regeneration and ability to target damaged tissues, exosomes represent a promising therapeutic avenue for OA treatment. Exosomes have potential in promoting cartilage repair, reducing inflammation and improving overall joint function. However, several challenges remain, including the need for standardized isolation and characterization methods, variability in exosomal content, and regulatory hurdles. The present review aims to provide a comprehensive overview of the current understanding of exosome mechanisms in OA and their therapeutic potential, while also addressing the ongoing challenges faced in translating these findings into clinical practice. By consolidating existing research, the present review aims to pave the way for future studies aimed at optimizing exosome‑based therapies for effective OA management.

References

Gurunathan S, Kang M, Song H, Kim N, Kim J . The role of extracellular vesicles in animal reproduction and diseases. J Anim Sci Biotechnol. 2022; 13(1):62. PMC: 9185900. DOI: 10.1186/s40104-022-00715-1. View

Rim Y, Nam Y, Ju J . The Role of Chondrocyte Hypertrophy and Senescence in Osteoarthritis Initiation and Progression. Int J Mol Sci. 2020; 21(7). PMC: 7177949. DOI: 10.3390/ijms21072358. View

Chen M, Wang Q, Wang Y, Fan Y, Zhang X . Biomaterials-assisted exosomes therapy in osteoarthritis. Biomed Mater. 2022; 17(2). DOI: 10.1088/1748-605X/ac4c8c. View

Zhou X, Cao H, Guo J, Yuan Y, Ni G . Effects of BMSC-Derived EVs on Bone Metabolism. Pharmaceutics. 2022; 14(5). PMC: 9146387. DOI: 10.3390/pharmaceutics14051012. View

Wu X, Crawford R, Xiao Y, Mao X, Prasadam I . Osteoarthritic Subchondral Bone Release Exosomes That Promote Cartilage Degeneration. Cells. 2021; 10(2). PMC: 7911822. DOI: 10.3390/cells10020251. View

Jin Y, Xu M, Zhu H, Dong C, Ji J, Liu Y . Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis. J Cell Mol Med. 2021; 25(19):9281-9294. PMC: 8500984. DOI: 10.1111/jcmm.16860. View

Huang L, Dong G, Peng J, Li T, Zou M, Hu K . The role of exosomes and their enhancement strategies in the treatment of osteoarthritis. Hum Cell. 2023; 36(6):1887-1900. DOI: 10.1007/s13577-023-00970-y. View

Asghar S, Litherland G, Lockhart J, Goodyear C, Crilly A . Exosomes in intercellular communication and implications for osteoarthritis. Rheumatology (Oxford). 2019; 59(1):57-68. DOI: 10.1093/rheumatology/kez462. View

Wang L, Xu H, Li X, Chen H, Zhang H, Zhu X . Cucurbitacin E reduces IL-1β-induced inflammation and cartilage degeneration by inhibiting the PI3K/Akt pathway in osteoarthritic chondrocytes. J Transl Med. 2023; 21(1):880. PMC: 10696753. DOI: 10.1186/s12967-023-04771-7. View

10.

Guimaraes I, Costa R, Madureira S, Borges S, Oliveira A, Pintado M . Tannic Acid Tailored-Made Microsystems for Wound Infection. Int J Mol Sci. 2023; 24(5). PMC: 10003198. DOI: 10.3390/ijms24054826. View

10.

Yadav A, Nandy A, Sharma A, Ghatak S . Exosome Mediated Cell-Cell Crosstalk in Tissue Injury and Repair. Results Probl Cell Differ. 2024; 73:249-297. DOI: 10.1007/978-3-031-62036-2_12. View

11.

Luo R, Liu M, Tan T, Yang Q, Wang Y, Men L . Emerging Significance and Therapeutic Potential of Extracellular vesicles. Int J Biol Sci. 2021; 17(10):2476-2486. PMC: 8315015. DOI: 10.7150/ijbs.59296. View

12.

Fu Y, Cui S, Zhou Y, Qiu L . Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation. Int J Mol Sci. 2023; 24(5). PMC: 10003468. DOI: 10.3390/ijms24054926. View

13.

Abramoff B, Caldera F . Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020; 104(2):293-311. DOI: 10.1016/j.mcna.2019.10.007. View

14.

Foo J, Looi Q, How C, Lee S, Al-Masawa M, Chong P . Mesenchymal Stem Cell-Derived Exosomes and MicroRNAs in Cartilage Regeneration: Biogenesis, Efficacy, miRNA Enrichment and Delivery. Pharmaceuticals (Basel). 2021; 14(11). PMC: 8618513. DOI: 10.3390/ph14111093. View

15.

Wang Z, Yan K, Ge G, Zhang D, Bai J, Guo X . Exosomes derived from miR-155-5p-overexpressing synovial mesenchymal stem cells prevent osteoarthritis via enhancing proliferation and migration, attenuating apoptosis, and modulating extracellular matrix secretion in chondrocytes. Cell Biol Toxicol. 2020; 37(1):85-96. DOI: 10.1007/s10565-020-09559-9. View

16.

Toh W, Lai R, Hui J, Lim S . MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. Semin Cell Dev Biol. 2016; 67:56-64. DOI: 10.1016/j.semcdb.2016.11.008. View

17.

Ju Y, Hu Y, Yang P, Xie X, Fang B . Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater Today Bio. 2023; 18:100522. PMC: 9803958. DOI: 10.1016/j.mtbio.2022.100522. View

18.

Zhang Y, Pizzute T, Pei M . A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration. Cell Tissue Res. 2014; 358(3):633-49. PMC: 4234693. DOI: 10.1007/s00441-014-2010-x. View

19.

Sun K, Luo J, Guo J, Yao X, Jing X, Guo F . The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020; 28(4):400-409. DOI: 10.1016/j.joca.2020.02.027. View